Keyword: Tandem Diabetes Care
The FDA has approved a new type of insulin pump that can be used with different components from other diabetes therapy systems.
Tandem Diabetes Care launched a new predictive feature for automatically pausing insulin delivery as a free update for its CGM-enabled insulin pumps.
CMS covers traditional insulin pumps, but not tubeless patch pumps, causing concern around innovation as well as patient access.
Here is Wednesday's dose of medtech news of note.
The FDA approved the integration of Tandem's touchscreen insulin pump and Dexcom's G5 CGM.
Here's this week's medtech news of note.
Tandem started a pivotal trial of a system that automatically stops insulin delivery when a patient’s blood glucose levels are predicted to fall.
Roche has joined partners Senseonics and TypeZero to develop a closed-loop system for insulin delivery.
Diabetes players Dexcom and Tandem Diabetes Care are joining forces with digital health company TypeZero Technologies on a closed-loop system for blood glucose control.
Tandem Diabetes Care and TypeZero Technologies have entered into an agreement to bring together TypeZero’s artificial pancreas tech and Tandem’s t:slim Insulin Pump.